Bill
H 2532
Overview: H 2532, An Act relative to therapeutic psilocybin treatment centers, Reporting date extended to Friday, December 19, 2025, February 27, 2025Purpose and Intent: This bill
Overview: H 2532, An Act relative to therapeutic psilocybin treatment centers, Reporting date extended to Friday, December 19, 2025, February 27, 2025
Purpose and Intent: This bill seeks to establish a regulatory framework for the legal use of psilocybin, the active compound in certain mushrooms, for therapeutic purposes in Massachusetts.
Key Provisions:
- Directs the Department of Public Health to develop regulations for the licensing and operation of psilocybin treatment centers
- Allows for the use of psilocybin-assisted therapy under the supervision of licensed mental health professionals
- Includes provisions for patient eligibility, dosage limits, security requirements, and quality control standards
Affected Parties and Impacts: The bill would impact individuals suffering from certain mental health conditions who may benefit from psilocybin-assisted therapy, as well as the mental health professionals and treatment providers who would be involved in delivering this new form of care.
Procedural and Timeline Considerations: The reporting date for this bill has been extended to Friday, December 19, 2025, indicating that the legislature is taking additional time to review and refine the legislation before further action.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
